What is the reason TrovaNow was created? 1 in every 13 cancer deaths in the U.S. is a pancreatic cancer death and about 70% of patients die within 1 year of diagnosis. We know with your help, we can change these numbers. 

When it comes to cancer, there’s no time to waste.

We know that with the right people and adequate funding we can make significant improvements in current pancreatic cancer survival rates. We are working hard to support the PRECEDE Consortium and its industry partners to develop first-of-its-kind tests for early detection. This includes research to identify biomarkers of abnormal pancreatic cells so we can intervene before they become invasive cancer cells.

We’re also focusing on people who have had multiple family members with pancreatic cancer or who have mutations linked to pancreatic cancer. These high risk individuals will help us intervene at the earliest possible time to markedly delay or prevent the formation of pancreatic cancer.

To tackle early detection and to develop a strategy that’s going to work, first we have to figure out who’s at risk.

One of the things we are doing  is to push for the identification of individuals who are in families with multiple members with pancreas cancer. We know that at least 10% of patients with pancreatic cancer actually carry a gene that puts them at risk for developing pancreatic cancer. That’s even absent from any family history of pancreas cancer.

If we can enroll more of these patients in our study, we can make sure they are effectively screened using genetic profiling and imaging techniques. And their data will help us develop more effective, less invasive tools for early detection. 

What Is The Best Charity For Pancreatic Cancer Research?

TrovaNOW is raising funds for PRECEDE – an international, multi-institutional collaborative consortium of world renowned experts in pancreatic cancer. Our goal is to increase the 5-year survival rate of patients diagnosed with pancreatic cancer from 12% to 50% in the next 10 years.

How You Can Help Early Detection Research

With your donation, we can change the world. It is our opportunity to elevate our voices to raise awareness and invite others to answer our call-to-action. It is a time to educate the world by sharing our stories, raise money for research and let patients know that we will never give up.

Hope for the future starts with you. With more research and funding, fewer lives will be taken. Join us in our mission to advance the detection and treatment of pancreatic cancer to transform the landscape of this disease and improve survival rates.

PRECEDE Consortium

The PRECEDE Consortium is an international network of over 40 academic medical centers around the world who are committed to early detection for pancreatic cancer.  We are studying people at high risk for developing the disease as part of our mission to improve survival rates. Through this effort, we are bringing together clinicians, basic researchers, patients, biopharmaceutical and technology companies to accelerate new approaches to early detection and prevention of pancreatic cancer.

The PRECEDE Consortium will be an innovation hub, disseminating new protocols and discoveries. We will apply a technology-rich, data-driven, integrated model of basic, translational, and clinical research to early detection and prevention.

We cannot accomplish all that we need to without working together. Learn how even a small donation can make a BIG impact. 

If you want more information about how to donate, just email us at trovanow@gmail.com or learn more by visiting our website www.trovanow.com